Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer

NCT00003536 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Stage IV Breast Cancer
Recurrent Breast Cancer

Interventions

DRUG: antineoplaston A10
DRUG: methotrexate
PROCEDURE: alternative product therapy
PROCEDURE: biological therapy
PROCEDURE: biologically based therapies
PROCEDURE: cancer prevention intervention
PROCEDURE: chemotherapy
PROCEDURE: complementary and alternative therapy
PROCEDURE: differentiation therapy

Sponsor

Burzynski Research Institute